Professional Documents
Culture Documents
Re-Creating The RNA World: in Vitro
Re-Creating The RNA World: in Vitro
phenotypic properties of a ribo-organism. DNA was catalytic functions were assumed by ribozymes in the past,
found to be a superior macromolecule for storing genetic then it should be possible to recreate such ribozymes in
information, and proteins were a fortuitous side-product the present. This prediction has been made implicitly or
of a complex ribozyme that could catalyze template- explicitly by a number of authors, both prior to, and
directed peptide-bond formation. The invention of the following, the actual discovery of catalytic RNA [2,7-12].
translation apparatus was likely to have been a cataclysmic
event that allowed superior protein catalysts to displace In accord with these predictions, in vitro selection has
biochemically complex, but less efficient, ribozymes. been used to generate a wide variety of new ribozymes.
Most of these evolutionary events occurred long before Two types of selection procedure have yielded catalysts.
the last common ancestor of modern life, the progenote, Indirect selection is similar to the protocols originally
gave rise to the three modern domains (eubacteria, used to isolate catalytic antibodies. Prudent et al. [13]
archaebacteria, and eukaryotes). Some vestiges of RNA's selected RNA molecules that can bind to a bridged
former greatness can, however, still be found in (catalyti- biphenyl analogue of the transition state of an isomeriza-
cally competent?) ribosomal RNA and its attendant trans- tion reaction. The binding species were found to be
fer RNAs, the nucleotide 'signatures' of ubiquitous cofac- ribozymes able to catalyze the isomerization of substrates
tors such as NAD and ATP, and perhaps in idiosyncratic chemically similar to the analogue. Direct selection
molecular fossils such as the group I self-splicing intron. requires that active RNA molecules in a pool alter them-
selves during the selection process in such a way as to
This scenario makes a strong prediction regarding the cat- allow their isolation. For example, Bartel and Szostak [14]
alytic functions that can be assumed by ribozymes. For were able to select RNA molecules able to ligate a primer
example, if NAD is a 'ribo-cofactor' descended from the sequence onto themselves from a random sequence pool.
RNA world, then it should be possible for at least some Conversely, Pan and Uhlenbeck [15] selected ribozymes
RNA sequences to act as dehydrogenases [6]. Similarly, that can use a lead cofactor to cleave themselves.
the fact that the cellular currency for energy, ATP, is a
nucleotide suggests that there may have been enzymes Lorsch and Szostak [16] forged a link between cofactor-
such as ribo-kinases. In fact, the RNA world hypothesis binding and catalysis by selecting ribo-kinases that can
necessarily assumes the existence of a wide variety of ribo- phosphorylate themselves from a pool of RNA mol-
zymes, with functions that would have spanned the bio- ecules in which a randomly varied sequence was placed
chemical reactions of intermediary metabolism. If these next to a previously selected binding site for ATP. The
RNA world REVIEW 1019
Award from the American Foundation for AIDS Research (A.E.), 25. Dai X, Mesmaekder AD, Joyce GF: Cleavage of an amide bond by a
the Pew Scholar Award in the Biomedical Sciences (A.E.), the ribozyme. Science 1995, 267:237-240.
Cottrell Scholar Award (A.E.), the Office of Naval Research grant 26. Szathmary E: Coding coenzyme handles: a hypothesis for the origin
of the genetic code. Proc Natl Acad Sci USA 1993, 90:
#N00014-93-1-0430 (A.E.), and the National Institutes of Health 9916-9920.
grant #PHS R01GM48175 (A.E.). 27. Giulio MD, Capobianco MR, Medugno M: On the optimization of
the physiochemical distances between amino acids in the evolution
of the genetic code. Theor Biol 1994, 168:43-51.
References 28. Woese CR, Dugre DH, Dugre SA, Kondo M, Saxinger WC: On the
fundamental nature and evolution of the genetic code. Cold Spring
1. Gilbert W: The RNA world. Nature 1986, 319:618. Harbor Symp Quant Biol 1966, 31:723-736.
2. Benner SA, Ellington AD, Tauer A: Modern metabolism as a 29. Shimizu M: Molecular basis for the genetic code. J Mol Evol 1982,
palimpsest of the RNA world. Proc Natl Acad Sci USA 1989, 86: 18:297-303.
7054-7058. 30. Yarus M: A specific amino-acid binding site composed of RNA.
3. Gold L, Tuerk C: Methods for Identifying Nucleic Acid Ligands. Science 1988, 240:1751-1758.
United States Patent #5270163, 1993. 31. Yarus M, Christian E: Genetic code origins. Nature 1989, 342:
4. Kramer FR, Mills DR, Cole PE, Nishihara T, Spiegelman S: Evolution 349-350.
in vitro: sequence and phenotype of a mutant RNA resistant to 32. Connell GJ, Illangasekare M, Yarus M: Three small ribooligonucleo-
ethidium bromide. JMol Biol 1974, 89:719-736. tides with specific arginine sites. Biochemistry 1993, 32:
5. Orgel LE: Selection in vitro. Proc R Soc Lnd [Biol] 1979, 205: 5497-5502.
435-442. 33. Yarus M: An RNA-amino acid complex and the origin of the
6. Visser CM: Evolution of bio catalysis 2. Nicotinamide and/or flavin- genetic code. New Biol 1991, 3:183-189.
containing RNA molecules as possible pre-genetic-code replicating 34. Yarus M: An RNA-amino acid affinity. In The RNA World. Edited by
oxido-reductases. J Mol Evol 1984, 14:301-306. Gesteland RF, Atkins JF. New York: Cold Spring Harbor Laboratory
7. Crick FHC: The origin of the genetic code. J Mol Biol 1968, 38: Press; 1993:205-217.
367-379. 35. Connell GJ, Yarus M: RNAs with dual specificity and dual RNAs
8. Orgel LE: Evolution of the genetic apparatus. Mol Biol 1968, 38: with similar specificity. Science 1994, 264:1137-1141.
381-393. 36. Illangasekare M, Sanchez G, Nickles T, Yarus M: Aminoacyl-RNA
9. White HB: Coenzymes as fossils of an earlier metabolic state. JMol synthesis catalyzed by an RNA. Science 1994, 267:643-647.
Evol 1976, 7:101-104. 37. Famulok M: Molecular recognition of amino acids by RNA-
10. Visser CM, Kellogg RM: Biotin. Its place in evolution. Mol Evol aptamers: an L-citrulline binding RNA motif and its evolution into
1978, 11:171-178. an L-arginine binder. J Am Chem Soc 1994, 116:1698-1706.
11. Joyce GF: RNA evolution and the origins of life. Nature 1989, 38. Giver L, Bartel D, Zapp M, Pawul A, Green M, Ellington AD: Selec-
338:21 7-224. tive optimization of the Rev-binding element of HIV-1. Nucleic
12. Benner SA, Cohen MA, Gonnet GH, Berkowitz DB, Johnsson KP: Acids Res 1993, 21:5509-5516.
Reading the palimpsest: contemporary biochemical data and 39. Famulok M, Szostak JW: Stereospecific recognition of tryptophan
the RNA world. In The RNA World. Edited by Gesteland RF, Atkins agarose by in vitro selected RNA. Am Chem Soc 1992 114:
IF. New York: Cold Spring Harbor Laboratory Press; 1993:27-70. 3990-3991.
13. Prudent JR, Uno T, Schultz PG: Expanding the scope of RNA cata- 40. Majerfeld I, Yarus M: An RNA pocket for an aliphatic hydrophobe.
lysis. Science 1994, 264:1924-1927. Nature Struct Biol 1994, 1:287-292.
14. Bartel DP, Szostak JW: Isolation of new ribozymes from a large pool 41. Davies J: What are antibiotics? Archaic functions for modern activi-
of random sequences. Science 1993, 261:1411-1418. ties. Mol Microbiol 1990, 4:1227-1232.
15. Pan T, Uhlenbeck OC: In vitro selection of RNAs that undergo 42. Davies J, von Ahsen U, Schroeder R: Antibiotics and the RNA
2+
autolytic cleavage with Pb . Biochemistry 1992, 31:3887-3995. world: a role for low-molecular-weight effectors in biochemical
16. Lorsch JW, Szostak JW: In vitro evolution of new ribozymes with evolution? In The RNA World. Edited by Gesteland RF, Atkins F.
polynucleotide kinase activity. Nature 1994, 371:31-36. New York: Cold Spring Harbor Laboratory Press; 1993:185-204.
17. Burgstaller P, Famulok M: Isolation of RNA aptamers for biological 43. von Ahsen U, Davies J, Schroeder R: Antibiotic inhibition of group I
cofactors by in vitro selection. Angew Chem Int Ed Engl 1994, ribozyme function. Nature 1991, 353:368-370.
33:1084-1087. 44. Stage TK, Hertel KJ,Uhlenbeck OC: Inhibition of the hammerhead
18. Lauhon CT, Szostak JW: RNA aptamers that bind flavin and nicotin- ribozyme by neomycin. RNA 1995, 1:95-101.
amide redox cofactors. J Am Chem Soc 1995, 117:1246-1257. 45. Schroeder R, Streicher B, Wank H: Splice-site selection and de-
19. Wilson C, Szostak JW: In vitro evolution of a self-alkylating coding: are they related? Science 1993, 260:1443-1444.
ribozyme. Nature 1995, 374:777-782. 46. Noller HF: Drugs and the RNA world. Nature 1991, 353:302-303.
20. Robertson DL, Joyce, GF: Selection in vitro of an RNA enzyme that 47. Zapp ML, Stern S, Green MR: Small molecules that selectively block
specifically cleaves single-stranded DNA. Nature 1990, 344: RNA binding of HIV-1 Rev protein inhibit Rev function and viral
467-468. production. Cell 1993, 74:969-978.
21. Beaudry A, Joyce GF: Directed evolution of an RNA enzyme. 48. Wang Y, Rando RR: Specific binding of aminoglycoside antibiotics
Science 1992, 257:635-641. to RNA. Chem & Biol 1995, 2:281-290.
22. Tsang J, Joyce GF: Evolutionary optimization of the catalytic 49. Lato SM, Boles AR, Ellington AD: In vitro selection of RNA lectins:
properties of a DNA-cleaving ribozyme. Biochemistry 1994, 33: using combinatorial chemistry to interpret ribozyme evolution.
5966-5973. Chem & Biol 1995, 2:291-303.
23. Lehman N, Joyce GF: Evolution in vitro of an RNA enzyme with 50. Wallis MG, von Ahsen U, Schroeder R, Famulok: A novel RNA
altered metal dependence. Nature 1993, 361:182-185. motif for neomycin recognition. Chem & Biol 1995, 2:543-552.
24. Piccirilli JA, McConnell TS, Zaug AJ, Noller HF, Cech TR: Amino-
acyl esterase activity of the Tetrahymena ribozyme. Science 1992,
256:1420-1424. Received: 14 July 1995.